Salicylic Acid

Description

Salicylic acid is present at a concentration of 17% in this formulation, which is designed for the effective removal of common and plantar warts. The product features a no-drip formula, enhancing its ease of use. It is packaged in a net weight of 0.25 ounces (7 grams).

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting tenderness and disrupting the normal footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

After washing the affected area, the wart should be soaked in comfortably warm water for 5 minutes. Following this, the area must be dried thoroughly. One drop of gel should be applied at a time to ensure sufficient coverage of each wart. The gel should be allowed to dry completely.

This procedure should be repeated once or twice daily until the wart is removed, with a maximum treatment duration of up to 12 weeks.

Contraindications

Use is contraindicated in the following situations:

• Application on moles, birthmarks, and warts with hair growing from them is prohibited due to the potential for adverse reactions.

• The product should not be applied to mucous membranes, including the nose, anus, genitals, and lips, as this may lead to irritation or injury.

• Avoid use on irritated, infected, or reddened skin to prevent exacerbation of these conditions.

• The product is contraindicated for genital warts and warts located on the face, as these areas may require specialized treatment.

• Individuals with diabetes or poor blood circulation should not use this product unless under the guidance and supervision of a healthcare professional, due to increased risk of complications.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire and flame to prevent any risk of ignition.

The product should not be applied in the following circumstances:

• On moles, birthmarks, and warts with hair growing from them.

• On mucous membranes, including the nose, anus, genitals, and lips.

• On irritated, infected, or reddened skin.

• On genital warts and warts located on the face.

• In individuals who are diabetic or have poor blood circulation, unless under the advice and supervision of a qualified healthcare professional, such as a doctor or podiatrist.

When using this product, it is crucial to take the following precautions:

• In the event that the product comes into contact with the eyes, it is imperative to flush the eyes with water for at least 15 minutes.

• Users should avoid inhaling vapors to minimize respiratory irritation.

This product must be kept out of reach of children. If ingested, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

If discomfort persists after application, it is advisable to consult a healthcare professional, such as a doctor or podiatrist, for further evaluation and management.

Side Effects

Patients should be aware that this product is for external use only and is flammable; it should be kept away from fire and flame. The product should not be used on moles, birthmarks, or warts with hair growing from them, nor should it be applied to mucous membranes such as the nose, anus, genitals, and lips. Additionally, it is contraindicated for use on irritated, infected, or reddened skin, as well as on genital warts and warts on the face. Patients who are diabetic or have poor blood circulation should only use this product under the advice and supervision of a doctor or podiatrist.

During the use of this product, if it comes into contact with the eyes, it is important to flush the eyes with water for 15 minutes. Patients should also avoid inhaling vapors associated with the product.

This product should be kept out of reach of children. In the event of accidental ingestion, medical help should be sought immediately, or contact a Poison Control Center. If discomfort persists after use, patients are advised to consult their doctor or podiatrist.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (wart remover gel). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The product has not been evaluated for safety in pregnancy, and its use is contraindicated due to potential risks to the fetus. There are no specific studies available regarding the effects of salicylic acid on pregnancy outcomes. Consequently, pregnant women should avoid using this product unless directed by a healthcare professional. While no dosage modifications are recommended for pregnant individuals, it is advised that they consult a healthcare provider prior to use to ensure safety and appropriateness.

Lactation

There is no specific information regarding the use of Salicylic Acid Wart Remover Gel in lactating mothers or any lactation considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when recommending this product to lactating mothers, as the effects on breastfed infants are not established.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert text regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients, although specific recommendations are not provided.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action and management procedures.

Healthcare providers should ensure that patients are monitored closely for any signs of toxicity and that supportive care is initiated as necessary.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use the product on moles, birthmarks, or warts with hair growing from them, as well as on mucous membranes, including the nose, anus, genitals, and lips. It is also important to caution patients against using the product on irritated, infected, or reddened skin, as well as on genital warts and warts located on the face.

For patients with diabetes or poor blood circulation, it is essential to advise that they should not use the product unless under the guidance and supervision of a healthcare professional, such as a doctor or podiatrist.

Healthcare providers should instruct patients that if the product comes into contact with the eyes, they should flush the eyes with water for 15 minutes. Additionally, patients should be warned to avoid inhaling vapors while using the product. If discomfort persists after use, patients should be encouraged to consult their doctor or podiatrist for further evaluation.

Storage and Handling

The product is supplied in configurations that adhere to the specified NDC numbers. It is essential to store the product in a controlled environment, maintaining a temperature range between 59°F to 86°F (15°C to 30°C).

Care should be taken to keep the product away from fire and flame to ensure safety and integrity. Proper storage conditions are crucial for maintaining the quality and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)